drug

Donepezil

MeSH D000077265
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by BeerYaakov Mental Health Center
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

3
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
NCT01490567Phase 4Unknown
Donepezil Double Blind Trial for ECT Memory Disfunction
NCT00465283Phase 4Unknown

KOLs & investigators

3
Helge Frieling, Prof., MDKOL score 5
Tali Nachshoni, MD
Xiaofeng Guo, doctor

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
BeerYaakov Mental Health Center
company
trial
Pharmacovigilance in Gerontopsychiatric Patients
PHASE3
trial
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
PHASE4
trial
Donepezil Double Blind Trial for ECT Memory Disfunction
PHASE4
trial
indication
Schizophrenia
indication
Depression
indication
Psychosomatic Disorders
indication
Epilepsy, Rolandic
indication
KOL
Helge Frieling, Prof., MD
KOL score 5
person
Tali Nachshoni, MD
KOL score —
person
Xiaofeng Guo, doctor
KOL score —
person